Kimberly Resnick

2.9k total citations · 1 hit paper
36 papers, 1.9k citations indexed

About

Kimberly Resnick is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, Kimberly Resnick has authored 36 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Reproductive Medicine and 10 papers in Surgery. Recurrent topics in Kimberly Resnick's work include Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Cancer Genomics and Diagnostics (5 papers). Kimberly Resnick is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Cancer Genomics and Diagnostics (5 papers). Kimberly Resnick collaborates with scholars based in United States, United Kingdom and Greece. Kimberly Resnick's co-authors include David E. Cohn, Hansjüerg Alder, Carlo M. Croce, John P. Hagan, Debra L. Richardson, Steven Waggoner, Kristine Zanotti, J. Michael Straughn, Kenneth H. Kim and Heather Hampel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Kimberly Resnick

34 papers receiving 1.9k citations

Hit Papers

The detection of differentially expressed microRNAs from ... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers

Kimberly Resnick
John W. Moroney United States
Scott McMeekin United States
Iván Díaz-Padilla United States
Sharad Ghamande United States
Frauke Bentzien United States
John W. Moroney United States
Kimberly Resnick
Citations per year, relative to Kimberly Resnick Kimberly Resnick (= 1×) peers John W. Moroney

Countries citing papers authored by Kimberly Resnick

Since Specialization
Citations

This map shows the geographic impact of Kimberly Resnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Resnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Resnick more than expected).

Fields of papers citing papers by Kimberly Resnick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Resnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Resnick. The network helps show where Kimberly Resnick may publish in the future.

Co-authorship network of co-authors of Kimberly Resnick

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Resnick. A scholar is included among the top collaborators of Kimberly Resnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Resnick. Kimberly Resnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taylor, Sarah E., Caitlin M. O’Connor, Zhizhi Wang, et al.. (2019). The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis. Cancer Research. 79(16). 4242–4257. 42 indexed citations
3.
Resnick, Kimberly & Kenneth J. Weiss. (2017). American Heiress: The Wild Saga of the Kidnapping, Crimes, and Trial of Patty Hearst. 45(1). 125–126. 4 indexed citations
4.
Nagaraj, Anil Belur, Peronne Joseph, Chunlei Zheng, et al.. (2017). Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment. Oncogene. 37(3). 403–414. 63 indexed citations
5.
6.
Singh, Sareena & Kimberly Resnick. (2017). Lynch Syndrome and Endometrial Cancer. Southern Medical Journal. 110(4). 265–269. 9 indexed citations
7.
Armstrong, Amy J., et al.. (2015). Patterns of First Recurrence in African American Patients with High Grade Epithelial Ovarian Carcinoma. Gynecologic and Obstetric Investigation. 81(3). 215–219. 1 indexed citations
8.
Redline, Raymond W., et al.. (2015). Fertility-sparing management of a stage IB1 small cell neuroendocrine cervical carcinoma with radical abdominal trachelectomy and adjuvant chemotherapy. SHILAP Revista de lepidopterología. 13. 5–7. 15 indexed citations
9.
James, Rebecca, et al.. (2013). An unusual presentation of a urethral diverticulum as a vaginal wall mass: a case report. Journal of Medical Case Reports. 7(1). 171–171. 3 indexed citations
10.
Kunos, Charles A., Tomas Radivoyevitch, Steven Waggoner, et al.. (2013). Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers. Gynecologic Oncology. 130(1). 75–80. 74 indexed citations
11.
Gold, Michael A., William E. Brady, Heather A. Lankes, et al.. (2012). A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study. Gynecologic Oncology. 125(3). 635–639. 41 indexed citations
12.
Kunos, Charles A., James Brindle, Steven Waggoner, et al.. (2012). Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies. SHILAP Revista de lepidopterología. 2. 181–181. 69 indexed citations
13.
Duan, Wenrui, Li Gao, Weiqiang Zhao, et al.. (2012). Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents. Translational research. 161(3). 156–164. 14 indexed citations
14.
Cohn, David E., Muller Fabbri, Nicola Valeri, et al.. (2010). Comprehensive miRNA profiling of surgically staged endometrial cancer. American Journal of Obstetrics and Gynecology. 202(6). 656.e1–656.e8. 85 indexed citations
15.
Resnick, Kimberly, J. Michael Straughn, Floor Backes, et al.. (2009). Lynch Syndrome Screening Strategies Among Newly Diagnosed Endometrial Cancer Patients. Obstetrics and Gynecology. 114(3). 530–536. 52 indexed citations
16.
Resnick, Kimberly, Heather Hampel, Richard Fishel, & David E. Cohn. (2009). Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. Gynecologic Oncology. 114(1). 128–134. 62 indexed citations
17.
Resnick, Kimberly, Hansjüerg Alder, John P. Hagan, et al.. (2008). The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecologic Oncology. 112(1). 55–59. 539 indexed citations breakdown →
18.
Leath, Charles A., Warner K. Huh, David E. Cohn, et al.. (2007). A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecologic Oncology. 105(3). 630–634. 140 indexed citations
19.
Cohn, David E., Kimberly Resnick, Nilsa C. Ramirez, & Carl Morrison. (2006). Advanced endometrial cancer with serous metastasis in a 17-year-old. Gynecologic Oncology. 101(2). 356–359. 6 indexed citations
20.
Cohn, David E., et al.. (2006). Non-Hodgkin's lymphoma mimicking gynecological malignancies of the vagina and cervix: a report of four cases. International Journal of Gynecological Cancer. 17(1). 274–279. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026